News & Publications

Industry News

Animal Health Institute Statement on NARMS Retail Meat Results

Washington, D.C. – Today’s National Antimicrobial Resistance Monitoring System’s 2012 Retail Meat report is significant and welcome. It shows that antibiotics can and are being used to effectively keep food animals healthy while minimizing the potential for transfer of resistant bacteria from animals to people. Antibiotic resistant is a major health concern, and the Centers […]

Read more »

FDA’s Survey of Milk Finds Few Drug Residues

The U.S. Food and Drug Administration announced results from its milk sampling survey, involving the testing of nearly 2,000 dairy farms for drug residues in milk. More than 99 percent of the samples are free of drug residues of concern– underscoring the safety of the US milk supply. These findings provide evidence that the nation’s […]

Read more »

Animal Healthcare Product Sales Stable in 2013

Media Contact: Ron Phillips: (202) 637-2440 Washington, D.C., January 14, 2015 – Spending by Americans on medicines used to protect the health of companion and farm animals was essentially unchanged in 2013 compared to 2012, not adjusted for inflation, according to figures released today by the Animal Health Institute. Sales for medicines for pets and […]

Read more »

AHI Statement on PEW Report on FDA Judicious Use Policy

Implementation of The Food and Drug Administration’s judicious use policy means medically important antibiotics will be used in food animals only to fight disease under the supervision of a licensed veterinarian. There is no loophole. The Pew report alleging that growth promotion uses might continue is wrong. There are 82 growth promotion claims that will […]

Read more »

AHI Statement on FDA Sales Data Report

Media Contact:           Ron Phillips:    (202) 637-2440 WASHINGTON, DC, October 2, 2014 – Today’s antibiotic sales data report from the Food and Drug Administration (FDA) is a small part of the story about the public health impact of antibiotics used to keep food animals healthy. National sales information is limited in its use and does […]

Read more »

AHI Comment on PCAST Report on Antibiotic Resistance

Antibiotic resistance is a serious public health threat. Like the 2013 Centers for Disease Control and Prevention (CDC) report on antibiotic resistance, President Obama’s Council of Advisors on Science and Technology (PCAST) report provides an important perspective and context on antibiotic resistance and the role of both human and animal medicine. The Animal Health Institute […]

Read more »

AHI Response to Reuters Story on Antibiotic Use in Chicken

Antibiotics are important tools used by producers and veterinarians to keep food animals healthy, which is essential to maintaining a healthy food supply. It is important to remember that they are only one of several tools and practices used. Animal health companies, producers and veterinarians work hard to minimize the need for antibiotics, use them […]

Read more »

FDA updates Lists of Feed Mill Licenses & VFD Distrbutor Notifcations (via FDA)

The U.S. Food and Drug Administration (FDA) recently updated its lists of Approved Medicated Feed Mill Licenses and Veterinary Feed Directive (VFD) Distributor Notifications. Licensed facilities are allowed to manufacture animal feeds from Category II, Type A medicated articles. A VFD drug is intended for use in animal feeds, and such use of the VFD […]

Read more »

FDA Announces FY 2015 Animal Drug User Fee Rates for ADUFA and AGDUFA (via FDA)

The U.S. Food and Drug Administration (FDA) announced in the Federal Register the fiscal year 2015 rates and payment procedures for animal drugs subject to user fees under the Animal Drug User Fee Amendments of 2013 (ADUFA III) and Animal Generic Drug User Fee Amendments of 2013 (AGDUFA II). These resources support FDA’s responsibilities to […]

Read more »

AHI Statement on Second Circuit Court of Appeals Decision upholding FDA action on Judicious use of Antibiotics

Today’s Second Circuit Court of Appeals decision supporting the Food and Drug Administration’s (FDA) decision to pursue a collaborative stakeholder process to implement significant changes to antibiotic use rather than a regulatory action is a welcome development.  The court joins the Center for Disease Control and the President’s Council of Advisors on Science and Technology […]

Read more »